人工耳蜗的医院协商定价
本研究对161家医院人工耳蜗装置的私人支付方协商价格进行横断面分析,发现价格在医院和支付方之间差异很大;尽管各厂商在人工耳蜗使用者结局上存在临床均衡,MED-EL装置价格(38478±2633美元)仍高于Cochlear Ltd.(34150±2418美元,p<.001);同一中心提供全部3个品牌时协商价格至少低5000美元(p<.05)。
要点
- 161家医院人工耳蜗装置协商价格在医院和支付方之间差异很大。
- MED-EL装置价格38478±2633美元,高于Cochlear Ltd.的34150±2418美元(p<.001)。
- 同一中心提供全部3个品牌时,协商价格至少低5000美元(p<.05)。
核心结论
- 尽管各厂商在人工耳蜗使用者结局上存在临床均衡,人工耳蜗装置价格在医院和支付方之间差异显著,MED-EL价格高于Cochlear Ltd.。
- 同一中心提供全部3个品牌时协商价格至少低5000美元(p<.05)。
- 需要进一步研究患者结局和医院业务量对价格的影响。
研究设计与样本
- 对人工耳蜗装置私人支付方协商价格进行横断面分析,共分析161家医院。
主要发现
- 价格在医院和支付方之间差异很大。
- MED-EL装置价格38478±2633美元,高于Cochlear Ltd.的34150±2418美元(p<.001)。
- Cochlear Ltd.装置加价分析显示,较公司平均销售价格(24649美元)平均加价58.5%±7.4%。
- 同一中心提供全部3个品牌时,协商价格至少低5000美元(p<.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究患者结局和医院业务量对价格的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Access to cochlear implantation can be restricted by financial burden, and little is known about the extent to which cochlear implant (CI) devices prices may vary between hospitals or manufacturers. We performed a cross-sectional analysis of private payer-negotiated prices for CI devices. In total, 161 hospitals were analyzed. Prices varied widely across hospitals and between payers. Despite clinical equipoise between manufacturers with regards to CI user outcomes, significant differences in prices were identified, with higher prices for MED-EL ($38,478 ± 2633) than for Cochlear Ltd. ($34,150 ± 2418, p < .001). Markup analysis for Cochlear Ltd. devices revealed a mean 58.5% ± 7.4% markup in excess of the company's average sales price ($24,649). Negotiated prices were also at least $5000 lower when all 3 brands were offered at the same center (p < .05). Further research examining the influence of patient outcomes and hospital volume on prices are needed.
引用
- Bartholomew RA, Rathi VK, Suresh K, et al. Hospital-Negotiated Pricing of Cochlear Implants. Otolaryngol Head Neck Surg. 2023. PMID: 36939617. doi:10.1002/ohn.280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。